Clinical Trials
2 trialsNCT04136808 2020-01-13
An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
Astellas Pharma Inc
Approved for marketing
NCT02589717 2016-11-02
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Genentech, Inc.
Approved for marketing